MA-NETCRACKER-TECHNOLOGY
3.6.2020 14:02:09 CEST | Business Wire | Press release
Netcracker Technology announced today the launch of its Netcracker 2020 portfolio to help service providers focus on their customer’s digital lifestyle. With Netcracker 2020 , service providers can transform customer engagement, dynamically evolve their digital ecosystems and reach new levels of automation and security, helping them to innovate and disrupt in the 5G digital economy.
Netcracker 2020 Digital BSS /OSS and Customer Engagement products and services have been redesigned and enhanced for the 5G era. The new digital portfolio is fully open and standards compliant, built for the cloud and allows service providers to develop their own enhancements or co-develop functions through a low code platform and blueprint delivery approach. With continuous short releases using Agile/DevOps processes, service providers gain faster access to innovative features with no disruptions to business operations. Central to Netcracker 2020 is an industry-leading security framework, designed to provide the highest level of proven system-wide security and privacy, which is critical in an era of increased cyber-attacks, intrusion and disruption.
In addition, as the world prepares for the uncertainty of a post COVID-19 environment, service providers want to increase the effectiveness of remote consumer and business interactions. With Netcracker 2020, they can radically transform customer engagement by anticipating their needs using AI-driven contextual interactions that go beyond problem solving and deliver relevant new services that combine service providers’ own services with those from partners and enriched with 5G experiences. As customers’ requirements become even more of a priority for service providers, personalized offerings can be dynamically created and delivered with a ground-breaking gaming-style user experience and cross-partner loyalty schemes.
Evolving to a more partner-based digital economy will require management of complex relationships, interconnections and business models with new and constantly changing partners, including other service providers. Netcracker 2020 helps build dynamic digital ecosystems that quickly adapt to changing business and market needs. With automated onboarding, simplified lifecycle management and partner-centric B2B2X opportunities, service providers will become both leaders and enablers of new platform-based monetization opportunities in diverse markets.
As services, networks and partnerships become more complex, full automation at every level has become a necessity. Netcracker 2020 uses a new operational model to remove manual tasks and drive hyper automation across network domains, services that cross domains, business processes and channels that are quickly moving towards open 5G networks with cloud-native functions and highly demanding edge cloud applications. Netcracker 2020 digital applications are cloud-native and designed to run in a multicloud environment, delivering the same high performance and resiliency on public clouds as on-premise cloud platforms. This also includes a security architecture and trust center that has become the industry benchmark.
“As BSS/OSS becomes increasingly critical to assure customer experience and enable security and flexible services, Netcracker has strengthened its position as the leader in helping service providers succeed in the highly competitive digital economy,” noted Sue Rudd, Director Networks and Service Platforms at Strategy Analytics. “Netcracker 2020 offers service providers a highly automated, multi-vendor microservices based environment to address their customers’ dynamic digital needs and sets the benchmark for modern BSS/OSS to accelerate revenue-generating service delivery in today’s uncertain world.”
“Netcracker 2020 is the culmination of over 25 years of experience of providing and operating mission-critical systems to hundreds of service providers around the globe in order to keep their businesses moving forward,” said Bob Titus, Chief Technology Officer, Netcracker. “This includes support for new business models, hyper automation, cloud adoption and the use of open source, outcome-based delivery models and, perhaps most importantly, an exceptional digital-first customer experience.”
About Netcracker Technology
Netcracker Technology, a wholly owned subsidiary of NEC Corporation, offers mission-critical digital transformation solutions to service providers around the globe. Our comprehensive portfolio of software solutions and professional services enables large-scale digital transformations, unlocking the opportunities of the cloud, virtualization and the changing mobile ecosystem. With an unbroken service delivery track record of more than 25 years, our unique combination of technology, people and expertise helps companies transform their networks and enable better experiences for their customers.
For more information, visit www.netcracker.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200603005135/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
REPLY: The Board of Directors Approves the Quarterly Report Dated 31 March 202615.5.2026 13:38:00 CEST | Press release
All economic and financial indicators grew:Consolidated revenues of €645.0 million (€607.5 million in 2025);EBITDA of €112.0 million (€105.3 million in 2025);EBIT of €95.1 million (€88.7 million in 2025);Profit before tax amounts to €99.8 million (€86.9 million in 2025). Today, the Board of Directors of Reply S.p.A. [EXM, STAR: REY] approved the results as at 31 March 2026. Since the beginning of the year, the Group has recorded a consolidated revenues amounting to €645.0 million, an increase of 6.2% compared to the corresponding data for 2025. All indicators are positive for the period. In the first quarter of 2026 the consolidated EBITDA stood at €112.0 million compared to €105.3 million in 2025, equal to 17.4% of the turnover. EBIT, from January to March, was €95.1 million (€88.7 million in 2025) and is equal to 14.7% of the turnover. The profit before tax, from January to March, was €99.8 million (€86.9 million in 2025), equal to 15.5% of the turnover. The net financial position of
Organon to Present New Research on Access and Value at ISPOR 202615.5.2026 13:30:00 CEST | Press release
New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolio Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data across women’s health, biosimilars, dermatology, and neurology at ISPOR 2026, the leading global scientific conference hosted by the International Society for Pharmacoeconomics and Outcomes Research. The conference, focused on health economics and outcomes research, will take place May 17-20, 2026, in Philadelphia, Pennsylvania. Across 8 accepted abstracts, the data reflect Organon’s commitment to generating real-world evidence—rooted in lived experiences—that can help inform healthcare decision-making and improve health outcomes across a range of therapeutic areas. “Health economics and outcomes research is critical to ensuring the right treatments reach patients and that
SES Announces Extraordinary General Meeting of Shareholders15.5.2026 08:30:00 CEST | Press release
SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme of 2 November 2023, as amended on 2 May 2024, in accordance therewith and pursuant thereto - Reduction of the share capital in accordance with article 450-5 of the law of 10 August 1915 on commercial companies, as amended, by forty-four million nine hundred ten thousand seven hundred eighty euro (EUR 44,910,780) through the cancellation of thirty-five million nine hundred and twenty-eight thousand six hundred and twenty-four (35,928,624) shares divided into (i) twenty-three million nine hundred and fifty-two thousand four hun
Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI15.5.2026 08:00:00 CEST | Press release
New global long‑term partnership embeds Experian’s Ascend capabilities directly into ServiceNow workflows, transforming client operations Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management and model life cycle governance use cases. A major challenge for global organisations adopting agentic AI is achieving scale, with deployments often constrained by a lack of trusted data. In fact, industry research shows that data limitations are the primary barrier for eight in ten organisations. By connecting trusted intelligence directly into enterprise workflows, this partnership e
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet15.5.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00596-9/fulltext) Integral-1 is a global, double-blind, randomized Phase III trial (jRCT2031230075) in patients with complicated urinary tract infection or acute uncomplicated pyelonephritis that compared the efficacy and safety of nacubactam co-administered with either cefepime or aztreonam versus imipenem-c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
